GenMark Diagnostics to Participate in Upcoming Investor Conferences
November 13, 2019 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...
GenMark Diagnostics Reports Third Quarter 2019 Results
November 06, 2019 16:03 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
GenMark Diagnostics Schedules Third Quarter 2019 Financial Results Conference Call for November 6, 2019
October 23, 2019 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Oct. 23, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close...
GenMark Diagnostics Reports Second Quarter 2019 Results
August 05, 2019 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
GenMark Diagnostics to Participate in the Canaccord Genuity Growth Conference
July 25, 2019 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...
GenMark Diagnostics Schedules Second Quarter 2019 Financial Results Conference Call for August 5, 2019
July 22, 2019 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close...
GenMark Diagnostics to Participate in Upcoming Investor Conferences
May 23, 2019 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...
GenMark Diagnostics to Present at the Bank of America Merrill Lynch Health Care Conference
May 01, 2019 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...
GenMark Diagnostics Reports First Quarter 2019 Results
April 30, 2019 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
GenMark Diagnostics Expands Commercial Team
April 30, 2019 16:02 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it...